Clinical trial
Anti-Malarial Drug Resistance in Cameroon
NCT00146718 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00146718 |
|---|---|
| Title | Anti-Malarial Drug Resistance in Cameroon |
| Official title | Anti-malarial Drug Resistance in Cameroon: Therapeutic Efficacy and Biological Markers of Resistance |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | University of Yaounde |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Amodiaquine and Sulphadoxine/Pyrimethamine |
| Enrollment | 755 |
| Start date | Aug 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Sep 7, 2005 |
| Last update posted | Jan 12, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: